Efficacy and Safety of Ba679BR Powder Inhalation in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT02172807 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

201

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: Tiotropium low
DRUG: Tiotropium high
DRUG: Placebo MDI
DRUG: Placebo inhalation capsule
DRUG: Oxitropium

Sponsor

Boehringer Ingelheim